We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
An overview of the process including submitting or fast tracking an application, naming your medicine and paying fees.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
The epidemiology, symptoms, diagnosis and management of Nipah virus infections.
This guidance provides information on COVID-19 in homelessness, domestic abuse refuge, respite room and asylum seeker accommodation settings.
Check what side effects people have reported when they've taken a medicine.
Launched in January 2024, IRP aims to further help bring life-saving new medicines to UK patients without delay
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Jan - 31 Mar 2024.
Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measures to reduce the identified risk of disabling and potentially long-lasting or...
Travel and clinical advice on Cyclospora including characteristics, symptoms, diagnosis and epidemiology.
Sanofi has informed us that there is an error in the Braille on some batches of Arava 10mg film-coated tablets (EL (17)A/01)
Information to assist with differentiating Lyme disease from other causes of rash, neurological or non-specific symptoms.
This amended guidance was issued under s 182 of the Licensing Act 2003.
Explains changes to drug driving law and the guidance available for healthcare professionals and users of prescription medicine.
Form L5 for identification of Clostridium botulinum, Clostridium perfringens, Clostridium tetani, Escherichia coli, helicobacter, listeria and yersinia.
medac GmbH (t/a medac Pharma LLP) is recalling further batches due to particles detected during long-term stability tests.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.